• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, February 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Regulation of feeding behavior and energy metabolism by galanin-like peptide (GALP)

Bioengineer by Bioengineer
December 24, 2018
in Health
Reading Time: 1 min read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The article by Dr. Seiji Shioda et al. is published in Current Pharmaceutical Design, 2018

Galanin-like peptide (GALP) is a short peptide made up of 60 amino acid residues. This sequence is homologous across several species. The hypothalamic arcuate nucleus is the place where GALP is produced. GALP has diverse physiological effects such as the regulation of feeding, energy metabolism, and reproductive behavior. Neurons that contain GALP also express leptin receptors; at the same time these neurons form a network in the hypothalamus and these contain various amounts of peptides that regulate their feeding behavior.

New research has shown that, GALP consists of anti-obesity action when it comes to its role in consumption of food and nutrition. After the administration of GALP into the lateral ventricle a decline in the respiratory quotient was also found. It is inferred that that because of GALP, lipid metabolism could be accelerated. This is a recently discovered physiological action for this peptide.

In this review, recent research about how GALP regulates feeding and energy metabolism has been summarized. Attention on the regulation mechanism of lipid metabolism that takes place in peripheral tissues through the autonomic nervous system is also given. The effectiveness of the nasal administration of GALP is also presented from a perspective of basic research and clinical application.

###

This article is Open Access. To obtain the article, please visit: http://www.eurekaselect.com/167067

Media Contact
Faizan ul Haq
[email protected]
http://dx.doi.org/10.2174/1381612824666181106111623

Tags: BiochemistryDevelopmental/Reproductive BiologyFertilityGynecologyMedicine/HealthMetabolism/Metabolic DiseasesNeurochemistryPharmaceutical SciencesPhysiology
Share12Tweet8Share2ShareShareShare2

Related Posts

Forensic Protein Analysis Reveals Time Since Death

February 2, 2026

Modified FOLFIRINOX Plus Nivolumab in Pancreatic Cancer Trial

February 2, 2026

Circulating Progenitor Cells Detect and Repair Aberrant Cells

February 2, 2026

MME Identified as Key Target of Notoginsenoside R1

February 2, 2026
Please login to join discussion

POPULAR NEWS

  • Enhancing Spiritual Care Education in Nursing Programs

    157 shares
    Share 63 Tweet 39
  • Robotic Ureteral Reconstruction: A Novel Approach

    81 shares
    Share 32 Tweet 20
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Forensic Protein Analysis Reveals Time Since Death

Unraveling Genome Growth in Acyclania tenebrosa

Modified FOLFIRINOX Plus Nivolumab in Pancreatic Cancer Trial

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.